Why did Hôpital de La Tour decide to sponsor our Digital Health Hub?
Hôpital de La Tour has been a pioneer at a Swiss and European level, with innovative projects aiming to improve both medical outcomes and efficiency in healthcare. These initiatives continue to demonstrate how central digitalisation is for any innovation in healthcare. We want to be at the forefront of the discussions in this regard.
What is the value of sponsorship collaborations like the one between Hôpital de La Tour and Biopôle?
The value of a collaboration like this one is twofold: it provides a source of inspiration for innovative thinking at La Tour and it is an opportunity for Biopôle start-ups to access the clinical world through the most important private hospital in French-speaking Switzerland.
My advice to start-ups is to go beyond listening to explicitly expressed needs.
How do you integrate digital solutions to improve patient’s health? Please detail some examples.
Last year we completed the transition to digitalised patient files; this was a very important step for driving efficiency and starting to generate information, which we can use in analytics and actionable reports. We are also working on an application to drive patient engagement on the care pathway. It is proven that outcomes are better when patients are engaged. This also contributes to a great patient experience.
What advice do you have for start-ups joining the initiative?
My advice to start-ups is to go beyond listening to explicitly expressed needs. A lot of digital innovations come from an external perspective of how things could run better within healthcare. It’s important to understand the constraints faced by hospitals when launching new applications in an already very fragmented IT landscape.
What kind of collaboration opportunities do you offer to start-ups?
We will open doors to start-ups that can help La Tour become a better hospital, delivering better outcomes and a better patient experience. They will get to interact with all necessary functions, doctors and caregivers in a private hospital of optimal size (i.e. 170 beds, allowing human scale with large-enough patient volumes).
Rodolphe Eurin holds a bachelor’s degree in Physics and a master’s in Industrial Management from ETH Zürich. He also has an MBA from IMD Business School in Lausanne.
Rodolphe Eurin boasts significant experience in international healthcare, having worked in the pharmaceutical industry with F. Hoffmann-La Roche in Basel and in medtech with Medtronic, where he was part of the EMEA management team for the spine and biologics department. After this, he managed Medtronic’s spine and neurological department in Scandinavia, before turning his sights to hospitals and healthcare. He worked as COO for a private clinic group before being appointed as Hôpital de La Tour CEO in late 2018.
Rodolphe Eurin’s passion lies in patient-oriented healthcare systems and he is driven by a belief that optimising medical outcomes will be a key differentiating factor for healthcare institutions in the future.
Hôpital de La Tour
Hôpital de La Tour is a private hospital based in Geneva that offers high-level acute care to patients. Pioneer in the value-based healthcare approach, La Tour places continuous improvement and medical excellence at the heart of its priorities. The hospital employs highly skilled medical staff and boasts state-of-the-art infrastructure.